These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36677641)
1. Effect of Autoclaving on the Physicochemical Properties and Biological Activity of Aluminum Oxyhydroxide Used as an Adjuvant in Vaccines. Skiba M; Fatmi S; Milon N; Bounoure F; Lahiani-Skiba M Molecules; 2023 Jan; 28(2):. PubMed ID: 36677641 [TBL] [Abstract][Full Text] [Related]
2. Autoclave-Induced Changes in the Physicochemical Properties and Antigen Adsorption of Aluminum Adjuvants. Yu G; Yang W; Zhang N; Yang C; Zeng H; Xue C; Sun B J Pharm Sci; 2024 Feb; 113(2):455-462. PubMed ID: 37813301 [TBL] [Abstract][Full Text] [Related]
3. Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease. Gherardi RK; Aouizerate J; Cadusseau J; Yara S; Authier FJ Morphologie; 2016 Jun; 100(329):85-94. PubMed ID: 26948677 [TBL] [Abstract][Full Text] [Related]
4. Effect of thermal treatment during the preparation of aluminum hydroxide adjuvant on the protein adsorption capacity during aging. Dandashli EA; Zhao Q; Yitta S; Morefield GL; White JL; Hem SL Pharm Dev Technol; 2002 Nov; 7(4):401-6. PubMed ID: 12503522 [TBL] [Abstract][Full Text] [Related]
5. Silicon or Calcium Doping Coordinates the Immunostimulatory Effects of Aluminum Oxyhydroxide Nanoadjuvants in Prophylactic Vaccines. Li M; Yao Z; Wang H; Ma Y; Yang W; Guo Y; Yu G; Shi W; Zhang N; Xu M; Li X; Zhao J; Zhang Y; Xue C; Sun B ACS Nano; 2024 Jul; 18(26):16878-16894. PubMed ID: 38899978 [TBL] [Abstract][Full Text] [Related]
6. Key Process Parameters Study for the Fill Finish of Vaccines Containing Aluminum Hydroxide Adjuvant. Yang Y; Su D; Yao X; Jin Z; Chen Q; Wu H; Guo J J Pharm Sci; 2024 Jun; 113(6):1478-1487. PubMed ID: 38246363 [TBL] [Abstract][Full Text] [Related]
7. Aluminum compounds used as adjuvants in vaccines. Shirodkar S; Hutchinson RL; Perry DL; White JL; Hem SL Pharm Res; 1990 Dec; 7(12):1282-8. PubMed ID: 2095567 [TBL] [Abstract][Full Text] [Related]
8. Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach. Fox CB; Orr MT; Van Hoeven N; Parker SC; Mikasa TJ; Phan T; Beebe EA; Nana GI; Joshi SW; Tomai MA; Elvecrog J; Fouts TR; Reed SG J Control Release; 2016 Dec; 244(Pt A):98-107. PubMed ID: 27847326 [TBL] [Abstract][Full Text] [Related]
9. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method. Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619 [TBL] [Abstract][Full Text] [Related]
10. Structure and properties of aluminum-containing adjuvants. Hem SL; White JL Pharm Biotechnol; 1995; 6():249-76. PubMed ID: 7551220 [TBL] [Abstract][Full Text] [Related]
11. Use of a quartz crystal microbalance platform to study protein adsorption on aluminum hydroxide vaccine adjuvants: Focus on phosphate-hydroxide ligand exchanges. Art JF; Soumillion P; Dupont-Gillain CC Int J Pharm; 2020 Jan; 573():118834. PubMed ID: 31715342 [TBL] [Abstract][Full Text] [Related]
13. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles. Sun B; Ji Z; Liao YP; Wang M; Wang X; Dong J; Chang CH; Li R; Zhang H; Nel AE; Xia T ACS Nano; 2013 Dec; 7(12):10834-49. PubMed ID: 24261790 [TBL] [Abstract][Full Text] [Related]
14. Stability of aluminium-containing adjuvants to autoclaving. Burrell LS; Lindblad EB; White JL; Hem SL Vaccine; 1999 Jun; 17(20-21):2599-603. PubMed ID: 10418908 [TBL] [Abstract][Full Text] [Related]
15. Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity. Li X; Hufnagel S; Xu H; Valdes SA; Thakkar SG; Cui Z; Celio H ACS Appl Mater Interfaces; 2017 Jul; 9(27):22893-22901. PubMed ID: 28621928 [TBL] [Abstract][Full Text] [Related]
16. Methods to Prepare Aluminum Salt-Adjuvanted Vaccines. Thakkar SG; Cui Z Methods Mol Biol; 2017; 1494():181-199. PubMed ID: 27718194 [TBL] [Abstract][Full Text] [Related]
17. NaCl strongly modifies the physicochemical properties of aluminum hydroxide vaccine adjuvants. Art JF; Vander Straeten A; Dupont-Gillain CC Int J Pharm; 2017 Jan; 517(1-2):226-233. PubMed ID: 27956190 [TBL] [Abstract][Full Text] [Related]
18. The Preparation and Physicochemical Characterization of Aluminum Hydroxide/TLR7a, a Novel Vaccine Adjuvant Comprising a Small Molecule Adsorbed to Aluminum Hydroxide. Malyala P; Laera D; Cianetti S; Bufali S; Aggravi M; Ianni E; Judge C; Otten G; Singh M; O'Hagan DT J Pharm Sci; 2018 Jun; 107(6):1577-1585. PubMed ID: 29421216 [TBL] [Abstract][Full Text] [Related]
19. Immobilization of Aluminum Hydroxide Particles on Quartz Crystal Microbalance Sensors to Elucidate Antigen-Adjuvant Interaction Mechanisms in Vaccines. Art JF; Vander Straeten A; Dupont-Gillain CC Anal Chem; 2018 Jan; 90(2):1168-1176. PubMed ID: 29224339 [TBL] [Abstract][Full Text] [Related]
20. Self-assembled aluminum oxyhydroxide nanorices with superior suspension stability for vaccine adjuvant. Bi S; Li M; Liang Z; Li G; Yu G; Zhang J; Chen C; Yang C; Xue C; Zuo YY; Sun B J Colloid Interface Sci; 2022 Dec; 627():238-246. PubMed ID: 35849857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]